2013 annual financial data

Relmada Therapeutics, Inc. 2013 Operating margin

Relmada Therapeutics, Inc. 2013 operating margin with verified reported values.

Direct answer

Operating margin was -877.66%.

Operating income was -45,015 USD and net income was -45,015 USD.
Operating cash flow was -11,859 USD.

Get free Relmada Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
5,129 USD
Operating income
-45,015 USD
Net income
-45,015 USD
Operating cash flow
-11,859 USD